![Louise Kooij](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermögen: 79 249 $ am 31.05.2026
Louise Kooij is currently Chief Accounting Officer at NewAmsterdam Pharma Co. NV since 2023.
Formerly, Ms. Kooij was Head-Finance & Operations at Azafaros BV from 2020 to 2023, Head-Rare Disease at Genzyme Therapeutics Ltd. from 2018 to 2020, Product Group Accountant at Hagemeyer NV, and Auditor at PricewaterhouseCoopers BV.
Ms. Kooij graduated from Nyenrode Business Universiteit.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 22.06.2026 | 2.353 ( 0 % ) | 79 249 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Comptroller/Controller/Auditor | 01.01.2023 |
| Unternehmen | Position | Ende |
|---|---|---|
Azafaros BV
 Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders | Finanzdirektor/CFO | 21.03.2023 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Corporate Officer/Principal | 01.01.2020 |
Hagemeyer NV
 Hagemeyer NV Wholesale DistributorsDistribution Services Distributes electrical parts and supplies | Corporate Officer/Principal | - |
PricewaterhouseCoopers BV
 PricewaterhouseCoopers BV Miscellaneous Commercial ServicesCommercial Services Provides audit, assurance, tax and consulting services | Comptroller/Controller/Auditor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 6 |
|---|---|
Hagemeyer NV
Hagemeyer NV Wholesale DistributorsDistribution Services Distributes electrical parts and supplies | Distribution Services |
Nyenrode Business Universiteit
 Nyenrode Business Universiteit Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops transformative therapies for patients affected by rare and debilitating diseases | Health Technology |
PricewaterhouseCoopers BV
PricewaterhouseCoopers BV Miscellaneous Commercial ServicesCommercial Services Provides audit, assurance, tax and consulting services | Commercial Services |
Azafaros BV
Azafaros BV Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for the treatment of rare metabolic disorders | Health Technology |
NewAmsterdam Pharma Co. NV
 NewAmsterdam Pharma Co. NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches, develops, manufactures and commercializes transformative therapies for cardio-metabolic diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
